Product introduction:
|
Product Name
|
Melanotan II
|
|
Appearance
|
White freeze-dried powder
|
|
Purity
|
98%min
|
|
Boiling point
|
1265.3ºC at 760 mmHg
|
|
Density
|
1.27 g/cm3
|
|
Refractive index
|
1.638
|
|
Single Impurity (HPLC)
|
1.0%max
|
|
Amino Acid Composition
|
±10% of theoretical
|
|
Peptide Content (N%)
|
≥80.0%
|
|
Water Content(Karl Fischer)
|
≤6.0%
|
|
Acetate Content (HPIC)
|
≤12.0%
|
|
MS(ESI)
|
Consistent
|
|
Mass Balance
|
95.0~105.0%
|
Factory Supply 99% Original Powder Hormone Peptide Mt2/Melanotan II CAS 121062-08-6 10mg/Vial for Injection with Safe Delivery and Cheap Price
Melanotan II (CAS No. 121062-08-6) was first synthesized at the University of Arizona. Researchers decided to find a more potent and stable alternative, one that would be more practical to defenses against skin cancer
The researchers headed by Victor Hruby, found a peptide, [Nle4, D-Phe7]-α-MSH, that was approximately 1, 000 times more potent than natural α-MSH after synthesizing and screening hundreds of molecules. They dubbed this new peptide, "Melanotan" (later Melanotan I, now known as afamelanotide). They subsequently developed another analog, AC-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2), which they named "Melanotan II Acetate". Since their discovery, numerous studies dating back to the MID-1980s have found no obvious toxic effects of the Melanotan peptides. The scientists hoped to use Melanotan peptides to combat melanoma by stimulating the body's natural tanning mechanism to create a tan without first needing exposure to harmful levels of UV radiation. This in turn, they hypothesized, could reduce the potential for skin damage that can eventually lead to skin cancer.